Cargando…
Tirofiban-induced thrombocytopenia
Tirofiban is a small non-peptide ligand-mimetic Glycoprotein (GP) IIb/IIIa inhibitor which can reversibly bind to the arginine-glycine-aspartic acid (RGD) recognition site of GP IIb/IIIa to prevent platelet aggregation. It reduces the incidence of thrombotic cardiovascular events in patients with no...
Autores principales: | Wang, Jun, Zou, Dongna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348023/ https://www.ncbi.nlm.nih.gov/pubmed/37439782 http://dx.doi.org/10.1080/07853890.2023.2233425 |
Ejemplares similares
-
Tirofiban-Induced Thrombocytopenia Occurring with Crohn's Disease
por: Ibrahim, Toni, et al.
Publicado: (2016) -
Severe thrombocytopenia following tirofiban infusion
por: Panduranga, Prashanth, et al.
Publicado: (2011) -
A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention
por: Yi, Yi-Hu, et al.
Publicado: (2018) -
Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2020) -
Case report: reuse of tirofiban leads to very severe thrombocytopenia
por: Li, Yuqing, et al.
Publicado: (2023)